The Allina Health Laboratory Consult Center, together with our Hospital Pathology Associates (HPA) partners, facilitates the transfer of pathology materials between Allina Health and other health care entities.Expedient and efficient sharing of these materials for either second opinions, or additional testing (i.e. genetic testing, etc.), ensures the continuum of quality patient care needed for both determination of diagnosis and optimum treatment options for our patients.

Consult Center FAQ's

Request for Materials

Request for Materials fax coversheet

Patient release of information

Consult Center Request

Consult Center Immunohistochemistry (IHC) Request

Consult Center Pathology Add-on Request

The following information is provided by CMS:

Date of service policy

In general, the date of service (DOS) for clinical diagnostic laboratory tests is the date of specimen collection, unless the physician orders the test at least 14 days following the patient’s discharge from the hospital. When the “14-day rule” applies, the DOS is the date the test is performed, rather than the date of specimen collection. 

In the CY 2018 Hospital Outpatient Prospective Payment System (OPPS)/Ambulatory Surgical Center (ASC) final rule published December 14, 2017, CMS established another exception to laboratory DOS policy for Advanced Diagnostic Laboratory Tests (ADLTs) and molecular pathology tests excluded from OPPS packaging policy so that the DOS is the date the test was performed, if certain conditions are met. This new exception to the laboratory DOS policy is effective beginning on January 1, 2018. Specifically, in the case of a molecular pathology test or an ADLT that meets the criteria of section 1834A(d)(5)(A) of the Social Security Act, the date of service must be the date the test was performed only if the following conditions are met: 

• The test is performed following a hospital outpatient’s discharge from the hospital outpatient department
• The specimen was collected from a hospital outpatient during an encounter (as both are defined 42 CFR 410.2)
• It was medically appropriate to have collected the sample from the hospital outpatient during the hospital outpatient encounter 
• The results of the test do not guide treatment provided during the hospital outpatient encounter
• The test was reasonable and medically necessary for the treatment of an illness.
   

If all of the above requirements are met, the DOS of the test must be the date the test was performed.

FoundationOne

NeoGenomics Laboratories, Inc.